Sabby Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Sabby Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-9	Closed	-$81K	–	205
2021 Q2	$81K	Sell	9 -11	-55%	-$1.05K	0.01%	151
2021 Q1	$227K	Buy	+20	New	+$2.22K	0.04%	133
2019 Q3	–	Sell	-5	Closed	-$137K	–	109
2019 Q2	$137K	Buy	+5	New	+$1.76K	0.17%	63
2019 Q1	–	Hold	0	–	–	–	79
2018 Q1	–	Sell	-3	Closed	-$46K	–	186
2017 Q4	$46K	Buy	+3	New	+$625	﹤0.01%	144
2017 Q2	–	Sell	-2	Closed	-$50K	–	262
2017 Q1	$50K	Sell	2 -4	-67%	-$1.18K	﹤0.01%	248
2016 Q4	$221K	Sell	6 -1	-14%	-$373	0.01%	237
2016 Q3	$254K	Buy	+7	New	+$2.45K	0.01%	263

Other funds holding CSCI

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Sabby Management's CSCI Position: Q3 2021 in Review

Sabby Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2021, closing a stake of 2,442 shares — an estimated $214K sold.

Sabby Management first reported a position in CSCI in Q4 2015 and held it in 11 quarters. The position peaked at $2.39M in Q4 2015. 31 funds tracked by Wall St. Rank hold CSCI as of Q3 2021.

Sabby Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Sabby Management sold 2,442 COSCIENS Biopharma Inc. Common Stock shares in Q3 2021, an estimated $214K.
Sabby Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 11 quarters.
Sabby Management's COSCIENS Biopharma Inc. Common Stock position peaked at $2.39M in Q4 2015.
31 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2021.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.